press enter »
placeholder
placeholder

Spain to trial mixing COVID-19 vaccines after restricting AstraZeneca shot
Spain to trial mixing COVID-19 vaccines after restricting AstraZeneca shot

Spain to trial mixing COVID-19 vaccines after restricting AstraZeneca shot

Reading Time: 2 minutes MADRID, April 19 (Reuters) – Spain will study the effects of mixing different coronavirus vaccines, government researchers said on Monday, responding to shifting guidelines on the safety of the AstraZeneca’s shot. Along with several other European countries, Spain has restricted vaccines produced by the Anglo-Swedish drug maker

Reports Spain mulling delaying second dose of Moderna and Pfizer shots

Reports Spain mulling delaying second dose of Moderna and Pfizer shots

Reading Time: < 1 minute Spain’s Health Ministry is considering delaying second doses of COVID-19 vaccines for under 80 year olds to maximise the number of people who have received at least one injection, El Mundo newspaper reported on Monday, citing an official document. Under the proposal, patients would receive a second shot of vaccines produced

Israeli study says South African variant may evade protection from Pfizer vaccine

Israeli study says South African variant may evade protection from Pfizer vaccine

Reading Time: 3 minutes The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is very low and the research has not been peer reviewed. The study, released in the weekend, compared almost

A new version of AstraZeneca vaccine to combat South African variant to be ready by end of 2021

A new version of AstraZeneca vaccine to combat South African variant to be ready by end of 2021

AstraZeneca’s Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were “too small to draw final conclusions”. A modified version of AstraZeneca’s COVID-19 vaccine tailored to combat a coronavirus variant

AstraZeneca could have COVID-19 vaccine against variant by end-2021

AstraZeneca could have COVID-19 vaccine against variant by end-2021

Reading Time: 2 minutes ZURICH, April 18 (Reuters) – A modified version of AstraZeneca’s COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday. Sarah Walters, AstraZeneca’s Austria country manager, told